{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T14:36:44Z","timestamp":1723214204910},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2011,8,11]],"date-time":"2011-08-11T00:00:00Z","timestamp":1313020800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0022929","type":"journal-article","created":{"date-parts":[[2011,8,11]],"date-time":"2011-08-11T22:58:35Z","timestamp":1313103515000},"page":"e22929","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["Latent Membrane Protein 1 Is Dispensable for Epstein-Barr Virus Replication in Human Embryonic Kidney 293 cells"],"prefix":"10.1371","volume":"6","author":[{"given":"Vicki","family":"Geiser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen","family":"Cahir-McFarland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elliott","family":"Kieff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2011,8,11]]},"reference":[{"key":"ref1","first-page":"2511","article-title":"Epstein Barr Virus and its replication.","author":"AB Rickinson","year":"2006"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1074-7613(00)80622-6","article-title":"EBV persistence in memory B cells in vivo.","volume":"9","author":"GJ Babcock","year":"1998","journal-title":"Immunity"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.1128\/JVI.71.7.4882-4891.1997","article-title":"Identification of the site of Epstein-Barr virus persistence in vivo as a resting B cell.","volume":"71","author":"EM Miyashita","year":"1997","journal-title":"J Virol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1128\/JVI.79.2.1296-1307.2005","article-title":"Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo.","volume":"79","author":"LL Laichalk","year":"2005","journal-title":"J Virol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"e1001338","DOI":"10.1371\/journal.ppat.1001338","article-title":"Epstein-Barr Virus Infection of Polarized Epithelial Cells via the Basolateral Surface by Memory B Cell-Mediated Transfer Infection.","volume":"7","author":"C Shannon-Lowe","year":"2011","journal-title":"PLoS Pathog"},{"key":"ref6","first-page":"2982","article-title":"Latent membrane protein 1 is critical for efficient growth transformation of human B cells by epstein-barr virus.","volume":"63","author":"U Dirmeier","year":"2003","journal-title":"Cancer Res"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"9150","DOI":"10.1073\/pnas.90.19.9150","article-title":"Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation.","volume":"90","author":"KM Kaye","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"6055","DOI":"10.1073\/pnas.100119497","article-title":"NF-kappa B inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cells.","volume":"97","author":"ED Cahir-McFarland","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1093\/emboj\/17.6.1700","article-title":"Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor.","volume":"17","author":"E Kilger","year":"1998","journal-title":"EMBO J"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"7070","DOI":"10.1002\/j.1460-2075.1996.tb01098.x","article-title":"Epstein-Barr virus latent membrane protein (LMP1) is not sufficient to maintain proliferation of B cells but both it and activated CD40 can prolong their survival.","volume":"15","author":"U Zimber-Strobl","year":"1996","journal-title":"EMBO J"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"13028","DOI":"10.1128\/JVI.78.23.13028-13036.2004","article-title":"Induction of Epstein-Barr virus latent membrane protein 1 by a lytic transactivator Rta.","volume":"78","author":"Y Chang","year":"2004","journal-title":"J Virol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1128\/JVI.80.5.2548-2565.2006","article-title":"Virus and cell RNAs expressed during Epstein-Barr virus replication.","volume":"80","author":"J Yuan","year":"2006","journal-title":"J Virol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.virol.2005.09.064","article-title":"Genome-wide transcription program and expression of the Rta responsive gene of Epstein-Barr virus.","volume":"345","author":"CC Lu","year":"2006","journal-title":"Virology"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"7610","DOI":"10.1128\/JVI.74.16.7610-7618.2000","article-title":"Hairy leukoplakia: an unusual combination of transforming and permissive Epstein-Barr virus infections.","volume":"74","author":"J Webster-Cyriaque","year":"2000","journal-title":"J Virol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1086\/422039","article-title":"Expression of Epstein-Barr virus latent genes in oral epithelium: determinants of the pathogenesis of oral hairy leukoplakia.","volume":"190","author":"DM Walling","year":"2004","journal-title":"J Infect Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1006\/viro.1998.9268","article-title":"Transcription of Epstein-Barr virus latent cycle genes in oral hairy leukoplakia.","volume":"248","author":"J Webster-Cyriaque","year":"1998","journal-title":"Virology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.1128\/JVI.79.7.4415-4424.2005","article-title":"Epstein-Barr virus transforming protein LMP1 plays a critical role in virus production.","volume":"79","author":"N Ahsan","year":"2005","journal-title":"J Virol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1128\/JVI.62.7.2337-2346.1988","article-title":"The truncated form of the Epstein-Barr virus latent-infection membrane protein expressed in virus replication does not transform rodent fibroblasts.","volume":"62","author":"D Wang","year":"1988","journal-title":"J Virol"},{"key":"ref19","first-page":"549","article-title":"The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain.","volume":"10","author":"DS Huen","year":"1995","journal-title":"Oncogene"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1093\/nar\/gkn273","article-title":"Conditional gene vectors regulated in cis.","volume":"36","author":"D Pich","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1099\/0022-1317-36-1-59","article-title":"Characteristics of a human cell line transformed by DNA from human adenovirus type 5.","volume":"36","author":"FL Graham","year":"1977","journal-title":"J Gen Virol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"16472","DOI":"10.1073\/pnas.0808019105","article-title":"Kinase requirements in human cells: I. Comparing kinase requirements across various cell types.","volume":"105","author":"DA Grueneberg","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"10139","DOI":"10.1128\/JVI.00854-06","article-title":"EBNA-3B- and EBNA-3C-regulated cellular genes in Epstein-Barr virus-immortalized lymphoblastoid cell lines.","volume":"80","author":"A Chen","year":"2006","journal-title":"J Virol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1002\/j.1460-2075.1989.tb08606.x","article-title":"The SV40 TC-II(kappa B) and the related H-2Kb enhansons exhibit different cell type specific and inducible proto-enhancer activities, but the SV40 core sequence and the AP-2 binding site have no enhanson properties.","volume":"8","author":"M Kanno","year":"1989","journal-title":"EMBO J"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1002\/j.1460-2075.1989.tb08607.x","article-title":"The SV40 TC-II(kappa B) enhanson binds ubiquitous and cell type specifically inducible nuclear proteins from lymphoid and non-lymphoid cell lines.","volume":"8","author":"M Macchi","year":"1989","journal-title":"EMBO J"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1128\/JVI.50.1.248-254.1984","article-title":"Detection of circular and linear herpesvirus DNA molecules in mammalian cells by gel electrophoresis.","volume":"50","author":"T Gardella","year":"1984","journal-title":"J Virol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"18448","DOI":"10.1073\/pnas.0809933105","article-title":"IRF7 activation by Epstein-Barr virus latent membrane protein 1 requires localization at activation sites and TRAF6, but not TRAF2 or TRAF3.","volume":"105","author":"YJ Song","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1146\/annurev.micro.112408.134016","article-title":"Genomes in conflict: maintaining genome integrity during virus infection.","volume":"64","author":"MD Weitzman","year":"2010","journal-title":"Annu Rev Microbiol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0042-6822(90)90302-8","article-title":"Sequence and transcription of Raji Epstein-Barr virus DNA spanning the B95-8 deletion region.","volume":"179","author":"BD Parker","year":"1990","journal-title":"Virology"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"13769","DOI":"10.1128\/JVI.79.21.13769-13777.2005","article-title":"Activation of Kaposi's sarcoma-associated herpesvirus lytic gene expression during epithelial differentiation.","volume":"79","author":"AS Johnson","year":"2005","journal-title":"J Virol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.virol.2010.10.023","article-title":"The lytic activation of KSHV during keratinocyte differentiation is dependent upon a suprabasal position, the loss of integrin engagement, and calcium, but not the interaction of cadherins.","volume":"410","author":"A Seifi","year":"2011","journal-title":"Virology"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1128\/JVI.78.7.3455-3461.2004","article-title":"Molecular evidence for rhesus lymphocryptovirus infection of epithelial cells in immunosuppressed rhesus macaques.","volume":"78","author":"JL Kutok","year":"2004","journal-title":"J Virol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1158\/0008-5472.CAN-06-3933","article-title":"Twist and epithelial-mesenchymal transition are induced by the EBV oncoprotein latent membrane protein 1 and are associated with metastatic nasopharyngeal carcinoma.","volume":"67","author":"T Horikawa","year":"2007","journal-title":"Cancer Res"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/344777a0","article-title":"Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation.","volume":"344","author":"CW Dawson","year":"1990","journal-title":"Nature"},{"key":"ref35","first-page":"62","article-title":"Stimulation of a human B-lymphocyte line by anti-immunoglobulin and its concanavalin A-induced suppression by a T-cell line.","volume":"30","author":"T Kishimoto","year":"1977","journal-title":"Clin Exp Immunol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"4506","DOI":"10.1128\/JVI.79.7.4506-4509.2005","article-title":"Epstein-Barr virus with the latent infection nuclear antigen 3B completely deleted is still competent for B-cell growth transformation in vitro.","volume":"79","author":"A Chen","year":"2005","journal-title":"J Virol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0022929","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T06:36:29Z","timestamp":1592807789000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0022929"}},"subtitle":[],"editor":[{"given":"Robert J.","family":"Geraghty","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2011,8,11]]},"references-count":36,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2011,8,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0022929","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,11]]}}}